PharMEDium Recalls ePHEDrine Sulfate Syringes Due to Sterility Concerns
PharMEDium Services is recalling 46 lots of ePHEDrine Sulfate syringes because the company could not ensure the products were sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance in an intravenous product, which poses a significant risk of infection and potential hospitalization.
Plain-English summary
PharMEDium Services, LLC is recalling 46 lots of ePHEDrine Sulfate, 5 mg per mL, 50 mg per 10 mL, in 0.9% Sodium Chloride 10 mL syringes. The recall was initiated because the firm could not guarantee the sterility of the products.
The affected product is intended for intravenous use and is preservative-free. The recall covers 1,075 units that were distributed nationwide in the United States. Specific lot numbers and expiration dates are listed in the official recall documentation.
Healthcare providers and patients should stop using the recalled syringes and contact PharMEDium Services for further instructions. The FDA has classified this recall as Class II, indicating a reasonable probability that use of the product could cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- ePHEDrine Sulfate, 5 mg per mL, 50 mg per 10 mL, In 0.9% Sodium Chloride 10 mL syringe, For IV Use Preservative Free PharMEDium 913 N. Davis Ave. Cleveland, MS NDC 71030-003-12
- Manufacturer
- PharMEDium Services, LLC
- Category
- Drug — IV Solution
- Affected units
- 1,075
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by PharMEDium Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · PharMEDium Services, LLC
See all →- SeverePharMEDium Recalls nICARdipine HCl Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls ePHEDrine Sulfate Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Infusions Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- ModeratePharmedium Recalls ePHEDrine Sulfate Syringes Due to Stability Data Concerns
FDA (Drugs) · 2016-10-19
- ModeratePharMEDium Recalls Ephedrine Sulfate Syringes Due to CGMP Deviations
FDA (Drugs) · 2018-08-15
- SeverePharmedium Recalls Ephedrine Sulfate Injection Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- SeverePharmakon Recalls Ephedrine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- HighPharmedium Recalls Subpotent Ephedrine Sulfate Syringes Nationwide
FDA (Drugs) · 2018-01-24
- SevereBanner Pharmacy Recalls Ephedrine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2017-11-01